SCHEMBL5059322

SCHEMBL5059322

CCOC(=O)C1C(=O)c2cc(Br)cc(C)c2N(CC)C1=O

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 1/20 0.40
MAPT P10636 6/20 0.38
TP53 P04637 5/20 0.38
ALDH1A1 P00352 4/20 0.36
HSD17B10 Q99714 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 2/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
MAPK1 P28482 6/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
TSHR P16473 5/20 0.33
CYP1B1 Q16678 1/20 0.32
APAF1 O14727 1/20 0.31
SMAD3 P84022 1/20 0.31
USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4535876 0.90 MAPT (0.38) TDP2MAPTTP53ALDH1A1HSD17B10
SCHEMBL4386782 0.71 ALDH1A1 (0.40) TDP2MAPTALDH1A1HSD17B10MEN1
SCHEMBL6693673 0.70 ALDH1A1 (0.41) MAPTALDH1A1HSD17B10MEN1KMT2A
SCHEMBL14796340 0.69 TDP2 (0.49) TDP2MAPTALDH1A1HSD17B10MEN1
SCHEMBL4528741 0.67 GAA (0.40) ALDH1A1MEN1KMT2AGAAUSP2
SCHEMBL7574847 0.66 TDP2 (0.48) TDP2MAPTALDH1A1HSD17B10MEN1
SCHEMBL4399697 0.65 ALDH1A1 (0.38) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL4399700 0.65 ALDH1A1 (0.38) MAPTALDH1A1MEN1KMT2AGAA
SCHEMBL6692389 0.65 ALDH1A1 (0.35) ALDH1A1MEN1KMT2AGAAKDM4E
SCHEMBL7519554 0.65 DRD2 (0.34) MAPTALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7470706-B2 Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-12-30 US disclosed
US-20050182087-A1 Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2005-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182087-A1 Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments SLC5A2, QPCT, GLS TDP2 3309/4885MAPT 4496/4885TP53 3197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.